Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
grade B 54.8727 2.41% 1.29
CRSP closed up 5.24 percent on Tuesday, November 12, 2019, on 2.97 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CRSP trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 2.41%
Expansion Breakout Bullish Swing Setup 2.41%
Pocket Pivot Bullish Swing Setup 2.41%
New 52 Week High Strength 2.41%
Wide Bands Range Expansion 2.41%
Overbought Stochastic Strength 2.41%
Up 3 Days in a Row Strength 2.41%
Up 4 Days in a Row Strength 2.41%
Up 5 Days in a Row Strength 2.41%
Stochastic Reached Overbought Strength 7.78%

Older signals for CRSP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Biology Immune System Genetics Serious Diseases Genetic Engineering Enzymes Genome Editing Cas9 CRISPR
Is CRSP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 56.16
52 Week Low 22.22
Average Volume 549,520
200-Day Moving Average 41.8941
50-Day Moving Average 44.1726
20-Day Moving Average 45.3515
10-Day Moving Average 50.179
Average True Range 2.7567
ADX 33.3
+DI 40.0641
-DI 12.0832
Chandelier Exit (Long, 3 ATRs ) 47.8899
Chandelier Exit (Short, 3 ATRs ) 44.7601
Upper Bollinger Band 56.4259
Lower Bollinger Band 34.2771
Percent B (%b) 0.87
BandWidth 48.838076
MACD Line 2.6369
MACD Signal Line 1.8236
MACD Histogram 0.8133
Fundamentals Value
Market Cap 2.17 Billion
Num Shares 40.6 Million
EPS -1.41
Price-to-Earnings (P/E) Ratio -38.00
Price-to-Sales 73.74
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 60.93
Resistance 3 (R3) 60.97 58.57 59.71
Resistance 2 (R2) 58.57 56.69 58.55 59.30
Resistance 1 (R1) 56.07 55.54 57.32 56.03 58.89
Pivot Point 53.67 53.67 54.29 53.65 53.67
Support 1 (S1) 51.17 51.79 52.42 51.13 48.27
Support 2 (S2) 48.77 50.64 48.75 47.86
Support 3 (S3) 46.27 48.77 47.46
Support 4 (S4) 46.23